Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group

Von Hippel-Lindau (VHL) disease is an autosomal dominant hereditary cancer syndrome that predisposes affected individuals to the development of multiple benign and malignant tumors. One of the main manifestations of VHL is renal cell carcinoma (RCC). RCC is increasingly being treated with targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oudard, Stéphane, Elaidi, Reza, Brizard, Mara, Rest, Céline Le, Caillet, Valérie, Deveaux, Sophie, Benoit, Gérard, Corréas, Jean-Michel, Benoudiba, Farida, David, Philippe, Gaudric, Alain, Hammel, Pascal, Joly, Dominique, Timsit, Marc Olivier, Méjean, Arnaud, Richard, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356738/
https://www.ncbi.nlm.nih.gov/pubmed/27852035
http://dx.doi.org/10.18632/oncotarget.13301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356738/
https://www.ncbi.nlm.nih.gov/pubmed/27852035
http://dx.doi.org/10.18632/oncotarget.13301

Ejemplares similares